Wedbush Has Bullish Outlook for Prime Medicine Q3 Earnings
Prime Medicine, Inc. (NYSE:PRME – Free Report) – Stock analysts at Wedbush boosted their Q3 2025 earnings per share (EPS) estimates for shares of Prime Medicine in a report released on Monday, May 19th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.32) for the quarter, up from […]
Prime Medicine, Inc. (NYSE:PRME – Free Report) – Stock analysts at Wedbush boosted their Q3 2025 earnings per share (EPS) estimates for shares of Prime Medicine in a report released on Monday, May 19th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.32) for the quarter, up from […]
